Vaccines

The vaccines market is significantly growing but these clinical trials require a specific expertise, i.e. patient recruitment constraints or very seasonal timelines for completing the studies.

In this context, BARC developed the necessary skills and infrastructure to serve its customers in this market. This includes highly specialized laboratories in both hemispheres with dedicated experts and experienced technicians for on time delivery of quality results. BARC also offers its’ customers expert consultancy in study design, custom-test development and technology or method transfer.

Through its parent company BARC has seamless access to remote countries like Africa, the Middle East and Asia where Cerba European Lab’s proven logistics can assure specimen retrieval for medical diagnosis on a daily or weekly basis.